1) Cinametic acid
利胆酸
2) ursodeoxycholic acid (UDCA)
熊去氧胆酸(利胆药)
3) intermediate of cinametic-acid
利胆酸中间体
4) cholagogic
[,kəulə'ɡɔdʒik]
利胆
1.
Anti-Inflammatory and Cholagogic Effects of Aucklandiae;
木香醇提取物的抗炎利胆作用
2.
OBJECTIVE To observe the analgesic,anti-inflammatory and cholagogic effect of Jindan Pian extract to mice.
目的观察金胆片浸膏对小鼠的镇痛、抗炎作用以及对大鼠的利胆作用。
3.
OBJECTIVE To observe the cholagogic,analgesic and antiinflammatory effects of danshutong tablets.
目的观察胆舒通片的利胆、镇痛、抗炎作用。
5) choleresis
利胆
1.
Objective: The purpose is to study the ethyl acetate extract from Herba Lysimachiae (EA) on anti gallstone and choleresis effects.
目的 :研究金钱草乙酸乙酯提取物 (EthylacetateextractfromHerbaLysimachiae ,EA)利胆排石的作用及其机理。
2.
Objective:To explore the effects of Yanggan Lidan Granule(YGLDG),a compound traditional Chinese herbal medicine for nourishing liver and improving choleresis,on the rate of gallstone formation and content of plasma cholecystokinin in guinea pigs with induced cholesterol gallstones.
目的:探讨养肝利胆颗粒对豚鼠胆囊胆固醇结石成石率和血浆胆囊收缩素含量的影响。
6) Bile acid
胆酸
1.
Liver targeted therapy with bile acid as the carrier;
以胆酸为载体的肝靶向疗法
2.
Mechanism of FXR receptor and BSEP on bile acid transport in placenta of ICP;
FXR、BSEP在ICP胎盘胆酸转运中的作用机制研究
3.
The characteristics of cholesterol, bile acid, hyperlipoproteinemia and the relationships among them are intro-duced.
在这些新型吸附剂的开发过程中,通过分子结构设计在骨架分子上引入活性基因,以期借助离子交换、静电引力、氢键及疏水键相互作用等与胆酸或胆固醇相结合,提高其吸附能力和选择性。
补充资料：利胆酸
分子式：C12H14O5
分子量：238.24
CAS号：35703-32-3
性质：白色结晶。熔点202-203℃。
制备方法：暂无
用途：暂无
分子量：238.24
CAS号：35703-32-3
性质：白色结晶。熔点202-203℃。
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条